Increasing evidence indicates that IVF (IVF includes in vitro fertilization and culture) embryos and babies are associated with a series of health complications, and some of them show sex-dimorphic patterns. Therefore, we hypothesized that IVF procedures have sex-biased or even sex-specific effects on embryonic and fetal development. Here, we demonstrate that IVF-induced side effects show significant sexual dimorphic patterns from the pre-implantation to the prenatal stage. During the pre-implantation stage, female IVF embryos appear to be more vulnerable to IVF-induced effects, including an increased percentage of apoptosis (7.22G1.94 vs 0.71G0.76, P!0.01), and dysregulated expression of representative sex-dimorphic genes (Xist, Hprt, Pgk1 and Hsp70). During the mid-gestation stage, IVF males had a higher survival rate than IVF females at E13.5 (male:femaleZ1.33:1), accompanied with a female-biased pregnancy loss. In addition, while both IVF males and females had reduced placental vasculogenesis/angiogenesis, the compensatory placental overgrowth was more evident in IVF males. During the late-gestation period, IVF fetuses had a higher sex ratio (male:femaleZ1.48:1) at E19.5, and both male and female IVF placentas showed overgrowth. After birth, IVF males grew faster than their in vivo (IVO) counterparts, while IVF females showed a similar growth pattern with IVO females. The present study provides a new insight into understanding IVF-induced health complications during embryonic and fetal development. By understanding and minimizing these sex-biased effects of the IVF process, the health of IVF-conceived babies may be improved in the future. Reproduction (2016) 151 443-453 q 2016 Society for Reproduction and Fertility
Introduction
IVF is widely used to treat infertility (ESHRE 2014); however, a small but worrying percentage suffer from a variety of IVF-associated risks, including pregnancy loss, preterm birth, birth defects and long-term disease risks (Hansen et al. 2005 , Ceelen et al. 2008 , Hart & Norman 2013 , Servick 2014 . Interestingly, these IVF-associated health complications are at least partially dependent on the gender of IVF offspring. For example, IVF is associated with higher risks of female-biased Rett syndrome (Arnaud & Feil 2005) and male-biased Autism (Fountain et al. 2015) , and some IVF-associated birth defects show sexually dimorphic patterns (Michalski et al. 2015) . Furthermore, sex-specific effects of IVF on postnatal metabolism and growth of IVF-conceived offspring has been confirmed in mouse models (Scott et al. 2010 , Feuer et al. 2014 ). More importantly, recent studies indicate that IVF results in a skewed sex ratio at birth (Dean et al. 2010 , Bu et al. 2014 , Maalouf et al. 2014 , reflecting sex-biased or even specific disruption of embryonic development. Indeed, the suboptimal environment is known to affect the embryonic development in a sex-specific manner as early as the pre-implantation stage, causing either a short-term sex ratio adjustment or more long-term sexspecific effects on adult health (Laguna-Barraza et al. 2012) . Therefore, we postulated that IVF has sex-biased or sex-specific effects on embryonic or fetal development during pregnancy.
Embryonic and postnatal phenotypic variability between males and females induced by environmental factors may occur through epigenetic mechanisms (Gutierrez-Adan et al. 2006 , Laguna-Barraza et al. 2012 . During the IVF process, both gametes and the pre-implantation embryos are exposed to in vitro conditions that do not perfectly recapitulate the normal environment of the Fallopian tube and uterus (Feuer & Rinaudo 2012) , in which genome-wide epigenetic reprogramming occurs (Reik 2007 , Cockburn & Rossant 2010 . Moreover, male and female embryos differ in their chromosomal complement, transcriptome, proteome and subsequent metabolome (Kobayashi et al. 2006 , Bermejo-Alvarez et al. 2010 , Gardner et al. 2010 , and in their epigenetic processes, including X-chromosome inactivation (XCI) (Takagi & Sasaki 1975) , DNA methylation (Bermejo-Alvarez et al. 2008 , Gebert et al. 2009 ) and gene imprinting (Kobayashi et al. 2006) . Therefore, variation in these epigenetic mechanisms between male and female preimplantation embryos may provide a molecular basis for the IVF-induced sex-biased or sex-specific effects.
In this study, using in vivo (IVO) conceived mouse embryos as controls, we investigated whether IVF has any sex-biased or sex-specific effects on embryonic or fetal development from pre-implantation to the prenatal stage. In addition, we aimed to explore the molecular basis behind these effects by monitoring the expression of related sex-dimorphic genes throughout these developmental stages in mice.
Materials and methods

Ethical approval
The protocols for the animal studies were approved by and performed in accordance with the requirements of the Institutional Animal Care and Use Committee of China Agricultural University.
Animals
We used female mice from the Institute for Cancer Research (ICR) aged 7-8 weeks and male ICR mice aged 10-12 weeks. The mice were allowed to feed ad libitum and housed under controlled lighting conditions (12 h light:12 h darkness photoperiod).
Chemicals
All chemicals used were purchased from the Sigma-Aldrich Chemical Company unless otherwise specified.
Experimental design
We used a well-established experimental design (Delle Piane et al. 2010 , Fauque et al. 2010 , Tan et al. 2015 to test the sex-biased or sex-specific effects of the IVF process from pre-implantation to the prenatal stage ( Fig. 1) . Briefly, all female mice were superovulated and randomly divided into two groups (IVO or IVF). After either in vivo fertilization and development (IVO group, control) or IVF and culture (IVF group), blastocysts in both groups were collected and transferred to pseudopregnant recipient mice. The samples of both groups were collected at blastocyst stage, E13.5 and E19.5 respectively. At blastocyst stage, welldeveloped late-cavitating blastocysts were collected at 96-100 h and 106-110 h post-hCG for the IVO and IVF groups respectively, according to previous descriptions about the developmental progress of IVO and IVF blastocysts (Giritharan et al. 2007) .
We performed immunofluorescence (IF) staining to count the inner cell mass (ICM) and trophectoderm (TE) cell numbers before each blastocyst was collected and sex was determined by PCR. For gene expression analyses, each blastocyst was individually collected and their sex was determined by PCR. After that, female (IVO, nZ34; IVF, nZ40) and male (IVO, nZ33; IVF, nZ40) blastocysts were pooled respectively. Finally, qRT-PCR was performed on the pooled females and males to ascertain gene expression. At E13.5 and E19.5, the developmental rates were recorded. Fetuses and placentas were collected, and their weights and sex were determined. At E13.5, the placentas were used for morphometric and geneexpression analyses. At E19.5, the pups from the litters (of any size) were used to generate birth data; however, only animals from litters with 5-8 pups were used in the postnatal growth curve, as previously described ).
Embryo preparation
The female mice were superovulated by intraperitoneal injection of 5 IU of pregnant mare serum gonadotropin and 5 IU hCG after 47 hours. In the IVO group, the superovulated female mice were mated individually with male mice. The following morning, successful mating was confirmed by detecting the presence of a vaginal plug. In the IVF group, IVF was performed as previously described (Nagy et al. 2003) . Briefly, cumulus-enclosed oocyte complexes were collected from the ampullae 14 h after the hCG injection, and sperm was obtained from the cauda epididymis and capacitated for 1 h in human tubal fluid (HTF) medium (Sage, Bedminster, NJ, USA) at 37 8C and 5% CO 2 . Gametes were co-incubated in HTF medium for 4 h. Fertilized oocytes were washed several times in potassium simplex optimization medium containing amino acids (KSOMCAA, Millipore, Billerica, MA, USA) and transferred to 60 ml drops of KSOMCAA medium covered with paraffin oil. The embryos were cultured at 37 8C with 5% CO 2 .
Blastocyst collection and embryo transfer
The criteria for collecting blastocysts for embryo transfer were based on developmental progress and morphology. IVO blastocysts were obtained from donor females by flushing the uterus with M2 medium (96-100 h post-hCG). According to previous reports, IVF embryos show delayed pre-implantation development (Giritharan et al. 2007 , Rivera et al. 2008 , Fernandez-Gonzalez et al. 2009 ). Therefore, as previously described (Giritharan et al. 2007) , only well-developed latecavitating blastocysts of similar morphology, based on the morphological landmark mentioned by Nagy et al. (2003) , were sampled (106-110 h post-hCG) for further analysis or selected for embryo transfer in each group. Naturally ovulating ICR female mice (aged 8 weeks), mated with vasectomized ICR males 3.5 days prior to embryo transfer, were used as recipients for both IVO and IVF embryo transfers. The morning after mating, the recipients were checked for the presence of a vaginal plug. The day of plugging was considered to be day 0.5 of the pseudopregnancy. Twelve blastocysts were surgically transferred to each recipient, with six blastocysts in each uterine horn.
Collection and morphometric analysis of post-implantation embryos
At E13.5, fetuses within their parietal and visceral yolk sac with intact placentas were dissected from their visceral yolk sac after removal of the parietal yolk sac. The sampled fetuses and placentas were weighed. Then, a proportion of placentas were placed in PBS supplemented with 4% (v/v) paraformaldehyde for 24 h and used to make paraffin sections, while the other placentas were collected for RNA extraction and detailed analyses, as described below. At E19.5, fetuses and placentas were sampled, as described for the E13.5 collection. Placentas were weighted and then placed in PBS supplemented with 4% (v/v) paraformaldehyde. The weight of fetuses was measured weekly until week 9.
Real-time quantitative PCR analysis
Each blastocyst was collected and treated with 7 ml ice-cold Cell Lysis II Buffer (plus the Armored RNA Control). Next, 2 ml of the lysis product was digested with proteinase K at 55 8C for 2 h, and used for sex determination with TaKaRa Ex Taq Hot Start Version (TaKaRa, Tokyo, Japan) according to the manufacturer's instructions. Rn18s and DYzEms3 were used for sex determination, as documented by previous studies , Rosenfeld 2012 . In female samples, only one amplicon corresponding to the Rn18S (91 bp) gene was detected. While in male samples, an additional amplicon corresponding to the Y chromosomespecific DyzEms3 segment (254 bp) was detected. The amplification conditions were as follows: initial denaturation for 3 min at 95 8C; 40 cycles of 10 s at 95 8C, annealing for 15 s at 52 8C, and elongation for 15 s at 72 8C s; and a 5 min extension at 72 8C. The remaining 5 ml of the lysis product was used to perform RT according to the manufacturer's protocol of the Cells-to-cDNA TM II Kit (Ambion, Austin, TX, USA).
Real-time PCR was performed using SsoFast EvaGreen Supermix (Bio-Rad) in a CFX96 real-time PCR machine (Bio-Rad). The amplification conditions were as follows: initial denaturation for 30 s at 95 8C and 40 cycles of 5 s at 95 8C, annealing and elongation for 5 s at 60 8C. Negative controls were either reactions without reverse transcriptase or with the RNA sample replaced by diethylpyrocarbonate treated MilliQ water (to test for any RNA or DNA contamination). Actb and glyceraldehyde-3-phosphate dehydrogenase (Gapdh) were used as the normalization control. Primer information is provided in Table 1 . A threshold was set where the Table 1 Primer sequences.
Gene name
Forward amplification was close to the reaction's maximum rate, which was not achieved in the negative controls. The threshold cycle (C t ) was used to calculate the relative quantity of the genes of interest in the cDNA sample. A plot of 2 K(normalized DC t ) is shown. At E13.5, five placentas (including spongiotrophoblast and labyrinth) from five litters of each group, with the wet weights closest to the mean weight of the litter, were pooled for total RNA extraction. The total RNA extraction from placentas of E13.5 embryos was performed using TRIzol (Invitrogen) according to the manufacturer's instructions. Before RT, RNA samples were digested with DNase I (Fermentas, Hanover, MD, USA) to remove the contaminating genomic DNA. The concentration and the quality of the extracted total RNA were assessed by the A260 nm/A280 nm and A260 nm/A230 nm ratios determined using a DS-11 spectrophotometer (Denovix, Wilmington, NC, USA). RT was accomplished by using the commercially available first strand cDNA synthesis kit (iScript cDNA synthesis kit, Bio-Rad Laboratories). The real-time quantitative PCR was performed as described above.
Apoptosis analysis
At the blastocyst stage, the embryos were washed three times with 0.1% polyvinyl alcohol (PVA)/PBS and then transferred to PBS supplemented with 4% (v/v) paraformaldehyde and 0.5% Triton X-100 for simultaneous fixation and permeabilization at 37 8C for 45 min. Apoptotic nuclei were detected by TUNEL assay using In Situ Cell Death Detection Kit (Roche). According to the manufacturer's instructions, fixed embryos were incubated in the TUNEL reaction medium for 1 h at 37 8C in the dark. After the reaction was stopped, the embryos were washed, transferred into a 2 mg/ml DAPI (4 0 , 6-diamidine-2 0penylindole dihydrochloride, Vector Laboratories Inc., Burlingame, CA, USA) solution and mounted on slides. The number of apoptotic nuclei and the total number of nuclei were determined under a confocal laser scanning microscope (Digital Eclipse C1, Nikon, Tokyo, Japan).
IF staining
IF staining was performed as previously described (Inoue et al. 2010) , with minor modifications. Briefly, embryos were fixed with 4% paraformaldehyde in PBS (pH 7.4) at 4 8C for 1 h and then permeabilized with PBS/0.5% Triton X-100/0.1% PVA (PBST (PBS/0.5% Triton X-100)-PVA) at room temperature for 1 h. After three washes with PBS/0.1% PVA at 37 8C for 10 min, the embryos were blocked in PBS/1% BSA at 4 8C for 6 h. Fixed embryos were then incubated with primary anti-CDX2 antibodies (1:200, Santa Cruz Biotechnology) overnight at 4 8C. Following three washes with PBST-PVA, the embryos were incubated with secondary antibodies conjugated with Alexa Fluor 488 (anti-mouse, Invitrogen) for 1 h at room temperature. Finally, the samples were counterstained with DAPI. The fluorescence signals were determined under a confocal laser scanning microscope (Digital Eclipse C1). The sex of each embryo was determined by PCR according to the method described above.
Histological and morphometric analysis of the placentas
At E13.5, at least one placenta, with the weight closest to the mean weight of the litter, was selected from each litter. These samples were fixed and then embedded in paraffin wax, and 6 (mm cross-sections were obtained and stained with hematoxylin and eosin. The resulting sections were observed and photographed under an epifluorescence microscope (BX51, Olympus). The border between the labyrinth and the spongiotrophoblast was identified visually and outlined using Photoshop software (Adobe). The border between maternal and fetal components of the placenta was identified by the presence of trophoblast giant cells; a continuous line connecting the trophoblast giant cells was created likewise using Photoshop. The total cross-sectional areas of fetal and labyrinthine zones were measured and calculated using the DP72 plug-ins Image Processing Toolkit (Olympus).
For endothelial staining of fetal blood vessels, a subgroup of placentas was stained for laminin (Sigma). Briefly, 6 (mm paraffin sections were deparaffinized and rehydrated in PBS. The sections were treated with blocking solution (1% BSA/PBS), and incubated with primary anti-laminin antibodies overnight at 4 8C. Following three washes with PBST-PVA, the embryos were incubated with secondary antibodies conjugated with Alexa Fluor 594 (anti-rabbit, Invitrogen) for 1 h at room temperature. Finally, the samples were counterstained with DAPI. The fluorescence signals were determined under an epifluorescence microscope (BX51, Olympus). As described previously (Rosenstein et al. 1998) , four regions (1 mm 2 ) within each image were sampled by using a per area ratio measurement, and the data were analyzed by Mann-Whitney U-test to determine significant differences between IVO and IVF placentas.
Statistical analysis
One-way ANOVA was used to compare the differences among the groups, followed by post-hoc comparisons using IBM SPSS statistics software version 20. Experimental replicate was incorporated as a covariate. Relative gene expression data was first subjected to arcsine transformation. The developmental rate of embryos to the blastocyst stage was assessed by binary logistic regression analysis. The sex ratio was calculated as the proportion of males (number of males/total number of embryos or fetuses) and compared with the naturally expected ratio (50%) using a corrected c 2 procedure (Kimura et al. 2005) .
Results
The effects of IVF on pre-implantation embryonic development At the blastocyst stage, the sex ratio (male/female) was not significantly changed in the IVF group compared with the IVO group (1.02 vs 1.05, Table 2 ). However, male IVF blastocysts had a higher total cell number compared with their female counterparts (54.22G1.02 vs 46.59G1.02, P!0.05, Table 3 ). In addition, male IVF blastocysts, but not females, had a significantly increased ratio of TE/ICM cells compared with IVO blastocysts (males: 2.64G0.11 vs 2.25G0.09, P!0.05; females: 2.43G0.11 vs 2.22G0.10, PO0.05, Table 3 ). Moreover, while the apoptosis rates of IVF male and female blastocysts was significantly higher than that of their IVO counterparts (P!0.05, Fig. 2A ), the increased rate of apoptosis in female IVF blastocysts was more pronounced than that in IVF males.
As differences in gene expression regulation between male and female pre-implantation embryos may explain the variable susceptibility to IVF, we detected several representative X-linked (Xist, Hprt, G6pdx and Pgk1) and autosomal (Slc2a3, Hsp70, Dnmt3a and Dnmt3b) genes that are differentially expressed between genders (Bermejo-Alvarez et al. 2011). Compared with their IVO counterparts, IVF males showed significant higher expression levels of G6pdx and Hsp70; while IVF females showed significantly higher the expression levels of Hprt, Pgk1, Hsp70 and significantly lower the expression level of Xist (Fig. 2B) .
The effects of IVF on mid-gestation placental and fetal development
At E13.5, we found that the implantation rate of IVF embryos was comparable with that of IVO embryos (Table 4 ). However, IVF embryos showed a significantly higher abortion rate compared with IVO embryos (23.64% vs 11.63%, P!0.05). Furthermore, the sex ratio (male/female) of IVF fetuses at E13.5 was significantly higher than the expected natural sex ratio (1.33 vs 1, P!0.05) (Table 4 ). Moreover, IVF fetal weight at E13.5 was significantly lower than that in the IVO group (112.84G7.87 mg vs 126.40G2.52 mg, P!0.05); but placental weight was similar between the two groups. We also observed a significantly higher ratio of placental/fetal weight for IVF males compared with the IVO group (0.68G0.03 vs 0.59G0.01, P!0.05), but not for IVF females (Table 5) .
Next, we analyzed the histological characteristics of the placenta at E13.5. Although the total placental area and labyrinth area in both male and female IVO placentas were comparable to their IVF counterparts, the ratio of labyrinth area to total placental area was significantly lower in IVF males and females compared with their IVO counterparts (males: 0.60G0.03 vs 0.67G0.02, P!0.05; females: 0.59G0.01 vs 0.66G 0.01, P!0.05, Fig. 3A ). As the labyrinth is crucial for the exchange of nutrients between maternal and fetal blood (Desforges & Sibley 2010) , we examined vasculogenesis in this area using laminin to stain blood vessels (Fig. 3B) . By quantifying the blood vessels per area, we showed that IVF fetuses had reduced placental vasculogenesis in the labyrinth layer compared with IVO fetuses (Fig. 3B) .
Based on the aberrant placental morphology, we attempted to determine whether IVF affects the expression of genes involved in placental development and nutrient transport. Previous studies have demonstrated that IVF can dysregulate the expression of genes involved in placental nutrient transport (Slc2a1, Slc2a3 and Slc38a4) (Chen et al. 2015) , as well as of imprinted genes that play an important role in placental development and function (Dlk1, H19, Igf2, Kcnq1ot1 and Snrpn) (Constancia et al. 2005 , Angiolini et al. 2006 . We found that compared with their IVO counterparts, IVF males showed significantly lower expression of Dlk1, Kcnq1ot1, Slc2a1, Slc2a3 and Slc38a4; while IVF females showed significantly lower expression of Dlk1 and Slc2a3 (Fig. 3C) .
The effects of IVF on late-gestation fetal and placental development and postnatal growth
At E19.5, the litter size in the IVF group (5.47G1.31, nZ15 litters) was significantly smaller than that in IVO group (6.75G1.42, nZ12 litters, P!0.05). The sex ratio (male/female) of IVF fetuses was significantly higher when compared with the expected natural ratio (1.48 vs 1, P!0.05, Table 6 ). Furthermore, both male and female IVF fetuses showed comparable weight to their IVO counterparts; while both male and female IVF placentas showed significantly higher weight than their IVO (Table 7 and Supplementary Table S1 , see section on supplementary data given at the end of this article). Correspondingly, the ratio of placental/fetal weight in the IVF group was higher than that of the IVO group for both males and females (Table 7) . We also detected the postnatal growth of males and females from birth until week 9. From birth to weaning (week 3), both IVF male and female mice had comparable weights to their IVO counterparts; however, after weaning, IVF males showed a significantly higher body weight gain, which was not observed in IVF females ( Fig. 4 and Supplementary Table S2 ).
Discussion
This study highlights the sex-biased effects of the IVF process on embryonic and placental development, and postnatal growth. We found that the IVF manipulation during the pre-implantation stage impacts embryonic and placental development, and that these IVF-induced effects can persist from the pre-implantation stage through to the postnatal period. Our results support the idea that the pre-implantation period constitutes a window of development sensitive to reprogramming (Lee & Bartolomei 2013 , and provide evidence that many of these IVF-induced effects are sex-biased. During the pre-implantation stage, the developmental potential of both female and male embryos was compromised by IVF; however, female embryos appear more vulnerable. Indeed, we showed that male preimplantation embryos cleaved faster than females under IVF conditions. As faster cleavage during pre-implantation stage can result in higher pregnancy and implantation rates (Lundin et al. 2001) , our results suggest that male IVF blastocysts may have a higher developmental potential. Moreover, while male and female IVF blastocysts had an increased apoptosis rate, as shown in previous studies (Hardy 1997 , the increased rate of apoptosis in female IVF blastocysts was more pronounced than that in IVF males. This sex-biased effect during the pre-implantation stage was supported by the expression pattern of genes that are crucial for early development. In particular, X-linked genes, Xist, Hprt and Pgk1, were significantly dysregulated in IVF female blastocysts, implying that XCI, a female-specific epigenetic event to balance the X-linked gene dosage between males and females during early The sex ratio was compared with the expected sex ratio (1.00) using a corrected c 2 procedure (*P!0.05). development, may be impaired. However, the long-term effect of this IVF-induced female-specific epigenetic error should be further investigated.
During the mid-gestation stage, E13.5 was selected for sampling based on developmental considerations, as the placental architecture and function is well established and spongiotrophoblast and labyrinthine areas can be clearly distinguished at this time (Delle Piane et al. 2010) . Although the implantation ability of IVF embryos was comparable with that of IVO embryos, we found that the abortion rate of IVF embryos is significantly higher than that of IVO embryos. Further analysis showed that this phenomenon is mainly attributed to IVF females, indicating that IVF embryos may have a female-biased developmental defect before the mid-gestation stage, leading to a female-biased pregnancy loss. This agrees with the above observation that female blastocysts are more vulnerable to the IVF process. Therefore, a Sex-biased effects of IVF disrupted female-specific epigenetic event, such as XCI, may also play a role in IVF-induced effects during the mid-gestation period. Indeed, previous studies show that impaired XCI by Xist mutation can result in significant female-specific lethality during the peri-implantation period (Hoki et al. 2011 , Senner et al. 2011 . Another possible explanation for the female-biased growth defects is the gender-specific disruption of other epigenetic events, such as gene imprinting and DNA methylation (Kobayashi et al. 2006 , Bermejo-Alvarez et al. 2008 , Gebert et al. 2009 ). We found both IVF males and females have an increased ratio of placental/fetal weight, which is considered as a marker of intrauterine stress (Barker et al. 1990 ). The increased ratio of placental/fetal weight observed in this study is similar to that described in human IVF pregnancies, where IVF offspring were associated with hypertension later in life (Barker et al. 1990 , Moore et al. 1996 , Koudstaal et al. 2000 . The reasons for the increased ratio of placental/fetal weight are likely complicated; one possible explanation involves a compensatory process for the depressed fetal growth or the impaired function of the placenta itself (Feuer et al. 2014 , Chen et al. 2015 . The placental/fetal weight ratio was higher for IVF males than IVF females. In part, this may be due to the higher TE/ICM ratio observed in IVF male blastocysts. These results suggest that although the growths of both male and female fetuses were depressed after the IVF process, male placentas may have a stronger compensatory potential.
Correspondingly, we examined some representative genes that are essential for placental development and nutrient transport, and found that Dlk1, Kcnq1ot1, Slc2a1, Slc2a3 and Slc38a4 were dysregulated in IVF males, while Dlk1 and Slc2a3 were dysregulated in IVF females. This observation implies that the mechanisms responsible for the placental overgrowth may vary between males and females. Dlk1 is a paternally expressed imprinted gene, which is a marker for a subpopulation of glycogen cells in the placenta, and is essential for nutrient metabolism (Yevtodiyenko & Schmidt 2006 , Charalambous et al. 2014 ). On the other hand, Kcnq1ot1 is a maternally imprinted gene that organizes a lineage-specific nuclear domain for epigenetic gene silencing (Redrup et al. 2009 ), and its decreased expression is accompanied with placental overgrowth (Chen et al. 2015) . Slc2a1, Slc2a3 and Slc38a4 are also well-documented genes involved in placental nutrient transport (Chen et al. 2015) . Our results suggest that both males and females have an impaired placental development and function; however, the placental compensatory effect is more evident in males. This observation also suggests that the sex-biased effects of IVF on pre-implantation embryos can persist after implantation.
At birth, there were no significant differences in fetal weight between IVO and IVF males and females. This phenomenon, that the differences in fetal weight observed at E13.5 disappear 6 days later (at E19.5), is in accordance with that reported by previous study (Bloise et al. 2012) , in which the relative IVF fetal weight to IVO controls is lowest at the mid-gestation stage. After that, differences in fetal weight between IVF and IVO embryos reduce gradually until they disappear. One plausible explanation is the compensatory effect due to the larger placentas in IVF groups compared with that in control groups (Bloise et al. 2012) . Indeed, we found evident placental overgrowth in IVF males and females. This overgrowth may be due to the dysregulated expression of some key genes responsible for placental development and function, as described above. Among the most striking effects following IVF was an alteration in the growth curve in male IVF mice; IVF males grew faster than their IVO counterparts and showed a significantly higher body weight after weaning, which cannot be observed in females. This suggests that the IVF has long-term sex-biased effects that can persist to postnatal period. Similarly, a previous study demonstrated that male IVF mice tend to have aberrant glucose tolerance and pancreatic defects, which may be Number of live pups/number of embryos transferred. ‡ The sex ratio was compared with the expected ratio (1.00) using a corrected c 2 procedure (*P!0.05). . Therefore, the use of atmospheric O 2 (20%), as was used in this study, may be a suboptimal culture condition which contributes to the IVF-induced aberrations (Rinaudo et al. 2006) . Future studies should be designed to define which particular constituent(s) in the culture medium and/or what oxygen concentration is responsible for IVF-induced sex-biased phenotypes.
Our present study showed that the sex ratio at birth was skewed in IVF offspring. Indeed, this phenomenon has been repeatedly reported in IVF embryos of domestic animals, especially in bovines (Avery et al. 1991 , Gutierrez-Adan et al. 2001 , Wrenzycki et al. 2002 , Torner et al. 2014 . However, in humans, a recent study on assisted reproductive technologies (ART) indicated that the sex ratio among abnormal embryos is malebiased during the pre-implantation stage, but is femalebiased among normal embryos (Orzack et al. 2015) . In the study by Orzack et al. (2015) , ART included both IVF and ICSI, and the sex ratio was determined for the combined IVF-and ISCI-produced embryos. In most previous studies, the sex ratios of IVF-or ICSI-produced embryos/offspring were analyzed separately, and IVF was shown to result in a male-biased sex ratio (Avery et al. 1991 , Gutierrez-Adan et al. 2001 , Wrenzycki et al. 2002 , Dean et al. 2010 , Maalouf et al. 2014 , Torner et al. 2014 , while ICSI resulted in a female-biased sex ratio (Bu et al. 2014 , Maalouf et al. 2014 , Tarin et al. 2014 . Therefore, ICSI and IVF may affect sex ratios via different mechanisms. Moreover, two recent epidemiologic analyses based on very large clinical populations confirmed the IVF-induced higher male birth rate (Dean et al. 2010 , Maalouf et al. 2014 , which is in agreement with our results in mice. Therefore, the different strategy of analysis (i.e. analyzing IVF and ICSI together or separately) may explain the inconsistencies among these studies.
To the best of our knowledge, the skewed sex ratio observed in this study had not been reported in mice before. One possible explanation for this is that the sex skewing in IVF mouse embryos occurs during the postimplantation stage, but not at the blastocyst stage. This makes it difficult to perform a population analysis of the sex ratio phenomenon based on a large sample sizes. Indeed, a skewed sex ratio induced by maternal dietary nutrition was observed in mice at birth (Rosenfeld et al. 2003 ), suggesting that a long-term analysis (i.e. at the embryo stage or at birth) is needed to confirm sex skewing in IVF-produced offspring.
In summary, we have found that the effects of the IVF process, including IVF and culture, on embryonic or fetal development showed significant and long-term sexual dimorphic patterns. Future studies should be directed at understanding the molecular mechanisms underlying the described findings, and preventing these sex-biased side effects by optimizing the IVF system. By specifically targeting these sex-biased side effects, we hope to reduce IVF-associated health risks and improve the health of IVF-conceived babies. This work was supported by grants from the National Natural Science Foundation of China (No. 31472092), and the National High-Tech R&D Program (Nos 2011AA100303 and 2013AA102506) . Sex-biased effects of IVF
